Pooled safety analyses from the teriflunomide clinical development program

被引：0
|
作者：
Leist, T. P. [1 ]
Freedman, M. S. [2 ,3 ]
Kappos, L. [4 ]
Olsson, T. P. [5 ]
Miller, A. E. [6 ]
Wolinsky, J. S. [7 ]
O'Connor, P. W. [8 ]
Benamor, M. [9 ]
Truffinet, P. [9 ]
Dukovic, D. [10 ]
Comi, G. [11 ]
机构：
[1] Thomas Jefferson Univ Hosp, Comprehens Multiple Sclerosis Ctr, Philadelphia, PA 19107 USA
[2] Univ Ottawa, Ottawa, ON, Canada
[3] Ottawa Hosp, Res Inst, Ottawa, ON, Canada
[4] Univ Basel Hosp, CH-4031 Basel, Switzerland
[5] Karolinska Inst, Stockholm, Sweden
[6] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[7] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
[8] Univ Toronto, Toronto, ON, Canada
[9] Genzyme, Chilly Mazarin, France
[10] Sanofi Rech, Bridgewater, NJ USA
[11] Uni Vita Salute San Raffaele, Milan, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P097
引用
收藏
页码：110 / 111
页数：2
相关论文
共 50 条
  • [21] Teriflunomide hepatic safety results: pooled data from three placebo-controlled studies
    Confavreux, C.
    Olsson, T. P.
    Comi, G.
    Freedman, M. S.
    Miller, A.
    Wolinsky, J. S.
    Kappos, L.
    Delhay, J. -L.
    Li, H.
    Truffinet, P.
    O'Connor, P.
    JOURNAL OF NEUROLOGY, 2013, 260 : S122 - S122
  • [22] Pregnancy Outcomes from The Teriflunomide Clinical Development Programme
    Kieseier, B.
    Benamor, M.
    Truffinet, P.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 934 - 934
  • [23] Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions
    Comi, Giancarlo
    Freedman, Mark S.
    Kappos, Ludwig
    Olsson, Tomas P.
    Miller, Aaron E.
    Wolinsky, Jerry S.
    O'Connor, Paul W.
    Benamor, Myriam
    Dukovic, Deborah
    Truffinet, Philippe
    Leist, Thomas P.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 5 : 97 - 104
  • [24] Effect of teriflunomide on lymphocyte and neutrophil counts: pooled analyses from four placebo-controlled studies
    Comi, G.
    Freedman, M. S.
    Kappos, L.
    Miller, A. E.
    Olsson, T. P.
    Wolinsky, J. S.
    Benamor, M.
    Dukovic, D.
    Truffinet, P.
    O'Connor, P. W.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 93 - 94
  • [25] POOLED ANALYSIS OF LONG-TERM SAFETY DATA FROM THE RESOLUTE CLINICAL TRIAL PROGRAM
    Manoharan, Ganesh
    Neumann, Franz-Josef
    Windecker, Stephan
    Leon, Martin
    Meredith, Ian
    Saito, Shigeru
    Serruys, Patrick
    Silber, Sigmund
    Yeung, Alan
    Belardi, Jorge
    Widimsky, Petr
    Mauri, Laura
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1733 - E1733
  • [26] POOLED ANALYSIS OF LONG-TERM SAFETY DATA FROM THE RESOLUTE CLINICAL TRIAL PROGRAM
    Atilio Belardi, Jorge
    Yeung, Alan
    Leon, Martin
    Serruys, Patrick
    Meredith, Ian
    Windecker, Stephan
    Silber, Sigmund
    Neumann, Franz-Josef
    Widimsky, Petr
    Saito, Shigeru
    Massaro, Joseph
    Mauri, Laura
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E211 - E211
  • [27] Updated pregnancy outcomes from the teriflunomide clinical development programme: retrospective analysis of the teriflunomide clinical trial database
    Kieseier, B.
    Stueve, O.
    Benamor, M.
    Delhay, J.
    Truffinet, P.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 223 - 224
  • [28] Safety and tolerability of apremilast up to 182 weeks: pooled analyses from Phase 3 clinical trials
    Papp, K.
    Sobell, J.
    Shah, K.
    Day, R.
    Chen, R.
    Paul, C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 : 67 - 68
  • [29] Safety and tolerability of apremilast up to 182 weeks: Pooled analyses from phase 3 clinical trials
    Papp, Kim
    Sobell, Jeffrey
    Shah, Kamal
    Day, Robert
    Chen, Rongdean
    Paul, Carle
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB269 - AB269
  • [30] Latest results from the pooled RESOLUTE clinical program
    Mauri, L.
    EUROPEAN HEART JOURNAL, 2011, 32 : 82 - 82
12345